New exercise program aims to boost activity and brain health in black community

NCT ID NCT07127965

Recruiting now Disease control Sponsor: University of Colorado, Boulder Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a goals-based exercise program designed with input from the Black community to help adults aged 45-65 exercise more. Participants will be randomly assigned to different goal-setting and exercise intensity groups. The study tracks activity levels, blood pressure, sleep, and biomarkers of cognitive aging over 12 months to see if the program improves health and slows cognitive decline.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Goal-setting and exercise intensity program
What this could lead to: If successful, this program could help Black adults exercise more, potentially reducing risks of heart disease, diabetes, and cognitive decline.
What could go wrong: This is an early-stage behavioral study with 226 participants, so results may not apply broadly. Exercise adherence can be challenging, and the program may not work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COGNITIVE DECLINE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Cognitive Dysfunction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COGNITIVE DECLINE

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••

Locations

Recreation Centers in the Boulder Area
RECRUITING

Boulder, Colorado, 80309, United States

Contact Email: •••••@•••••
Recreation Centers in the Denver Metro Area
RECRUITING

Aurora, Colorado, 80309, United States

Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.